SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will strive to win its first order with its proprietary antibody-drug conjugate (ADC) platform this year, its new chief said.“Our goal is to win the first order this year,” Lotte Biologics Chief Executive James Park said at the JP Morgan Healthcare Conference on Thursday.“We will introduce our company’s vision to potential customers at the Syracuse Campus.”Park, who took the helm of the Korean pharmaceutical contract development and manufacturing organization (CDMO) last month, also unveiled the company’s novel ADC platform, SoluFlex Link, to audiences at the conference.
Lotte Biologics will then use the Syracuse facilities to offer ADC CDMO services in North America, said Park.“We will be able to meet diverse demands of our client spanning from clinical to commercial production, a big advantage (of using our service),” explained the CEO.
Lotte Biologics acquired a drug manufacturing plant from US-based multinational pharmaceutical company Bristol Myers Squibb (BMS) in Syracuse, New York, for $160 million in 2022.
The story "Lotte Biologics eyes first ADC CDMO order in 2025" has 685 words across 29 sentences, which will take approximately 3 - 6 minutes for the average person to read.
Which news outlet covered this story?
The story "Lotte Biologics eyes first ADC CDMO order in 2025" was covered 8 hours ago by Korea Economic Daily, a news publisher based in South Korea.
How trustworthy is 'Korea Economic Daily' news outlet?
Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.
The outlet is headquartered in South Korea and publishes an average of 6 news stories per day.
It's most recent story was published 5 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
